Maintenance of cognitive performance and mood for individuals with Alzheimer’s disease following consumption of a nutraceutical formulation: a one-year, open-label study
Manuscript Number:
15-1098R1
Author(s):
Cynthia Bechtel, David Larsen, Christopher Morrell, Robert Page, Ruth Remington, Annmarie Samar, Thomas B. Shea
Disclosures
Cynthia Bechtel
Nothing to Disclose
David Larsen
Nothing to Disclose
Christopher Morrell
Nothing to Disclose
Robert Page
Nothing to Disclose
Ruth Remington
Nothing to Disclose
Annmarie Samar
Nothing to Disclose
Thomas B. Shea
Equity:
Stock and stock options in Sevo Nutraceuticals, who markets the formulation used in this study, as Perceptiv
Patents/Royalties
My institution (UMass Lowell) and I receive royalties from the sale of Perceptiv by Sevo Nutraceuticals.
I am the lead inventor of a US patent on this formulation.